کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1983475 | 1539879 | 2015 | 10 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
LEUagonist concentration that produces 50% AChR activationNCAAChREC50IC50PSADMEMBSA - BSADulbecco's modified Eagle Medium - Eagle Medium اصلاح شده Dulbeccobovine serum albumin - آلبومین سرم گاوNoncompetitive antagonist - آنتاگونیست غیر رقابتیSER - برای بودنDissociation constant - حد تفکیکRoom temperature - دمای اتاقConformational states - دولت های سازگارStructure–activity relationship - رابطه ساختار-فعالیتSerine - سرینHill coefficient - ضریب هیلLeucine - لوسینMolecular modeling - مدل سازی مولکولیAllosteric modulation - مدولاسیون آلوستریکPolar surface area - منطقه قطبیinhibition constant - مهار ثابتnicotinic acetylcholine receptor - گیرنده استیلکولین نیکوتین
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
زیست شیمی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
To characterize the interaction of coronaridine congeners with human (h) α3β4 nicotinic acetylcholine receptors (AChRs), structural and functional approaches were used. The Ca2+ influx results established that coronaridine congeners noncompetitively inhibit hα3β4 AChRs with the following potency (IC50's in μM) sequence: (â)-ibogamine (0.62 ± 0.23) â¼Â (+)-catharanthine (0.68 ± 0.10) > (â)-ibogaine (0.95 ± 0.10) > (±)-18-methoxycoronaridine [(±)-18-MC] (1.47 ± 0.21) > (â)-voacangine (2.28 ± 0.33) > (±)-18-methylaminocoronaridine (2.62 ± 0.57 μM) â¼Â (±)-18-hydroxycoronaridine (2.81 ± 0.54) > (â)-noribogaine (6.82 ± 0.78). A good linear correlation (r2 = 0.771) between the calculated IC50 values and their polar surface area was found, suggesting that this is an important structural feature for its activity. The radioligand competition results indicate that (±)-18-MC and (â)-ibogaine partially inhibit [3H]imipramine binding by an allosteric mechanism. Molecular docking, molecular dynamics, and in silico mutation results suggest that protonated (â)-18-MC binds to luminal [i.e., β4-Phe255 (phenylalanine/valine ring; position 13â²), and α3-Leu250 and β4-Leu251 (leucine ring; position 9â²)], non-luminal, and intersubunit sites. The pharmacophore model suggests that nitrogens from the ibogamine core as well as methylamino, hydroxyl, and methoxyl moieties at position 18 form hydrogen bonds. Collectively our data indicate that coronaridine congeners inhibit hα3β4 AChRs by blocking the ion channel's lumen and probably by additional negative allosteric mechanisms by interacting with a series of non-luminal sites.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: The International Journal of Biochemistry & Cell Biology - Volume 65, August 2015, Pages 81-90
Journal: The International Journal of Biochemistry & Cell Biology - Volume 65, August 2015, Pages 81-90
نویسندگان
Hugo R. Arias, Katarzyna M. Targowska-Duda, Dominik Feuerbach, Krzysztof Jozwiak,